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ABSTRACT
Common variable immunodeficiency (CVID) is the most frequent primary immunodeficiency and has a reported prevalence of 
approximately 1:25,000 to 1:50,000. The fact that it is rarely considered as a diagnosis in adults can lead to diagnostic delay, especially in 
older patients, and to complications such as bronchiectasis and excess mortality. However, practitioners should first exclude common causes 
of hypogammaglobulinaemia before considering CVID. Here we present a case of CVID revealed by prolonged fever and complicated with 
granulomatous manifestations and bronchiectasis in an older woman without a history of recurrent infections. 
LEARNING POINTS
• Common variable immunodeficiency (CVID) should be considered in atypical cases with unexplained chronic signs such as fever of 
unknown origin (even in older patients) after tuberculosis, HIV, neoplasia and connective tissue disease have been ruled out.
• Common causes of hypogammaglobulinaemia should be excluded before CVID is considered.
• CVID can mimic sarcoidosis.
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CASE PRESENTATION
Common variable immunodeficiency (CVID) is the most frequent primary immunodeficiency. It is characterized by low levels of 
immunoglobulins IgG, IgA and sometimes IgM, which result in recurrent and severe infections, associated in some cases with autoimmune 
manifestations and granulomatous lesions[1,2]. The fact that it is rarely considered as a diagnosis in adults can lead to diagnostic delay, 
especially in older patients.
The case presented here is interesting because of its late onset. It is important for practitioners to remember that a diagnosis of primary 
immunodeficiency is still possible in older patients, especially those with atypical clinical features that remain unexplained after routine 
work-up. 
A 63-year-old woman presented with prolonged fever and poor physical condition for several months. Her personal history was 
unremarkable, but her husband had been treated for pulmonary tuberculosis 7 years previously. She had a family history of systemic lupus 
in her sister, autoimmune hypothyroidism in her brother and Grave’s disease in her daughter. 
Fever and weight loss were associated with liquid diarrhoea and a chronic dry cough. The patient was first admitted to the infections 
department, where she was investigated for HIV, tuberculosis (TB) and malignancy. Results showed anaemia (haemoglobin 10 g/dl), 
lymphopenia, inflammatory syndrome (ESR 73 mm, CRP 68 mg/l), a negative tuberculin skin test, negative HIV serology, and negative blood 
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and stool cultures. A CT scan (Fig. 1) showed micronodular and interstitial infiltrates associated with bronchiectasis, which can indicate TB. 
Three sputum smears were negative for TB. Because of the digestive system involvement, a gastro-intestinal endoscopy was performed and 
showed nodular gastritis and colitis and isolated giardiasis, which was treated with metronidazole with a good response.
The patient was discharged with a prescription for anti-TB drugs which she took for 9 months without any bacteriological or histological 
evidence of TB. However, the clinical course was marked by the occurrence of diffuse arthritis and lymphadenopathy and previous clinical 
and radiological signs persisted. Consequently, as systemic disease was suspected, the patient was admitted to the internal medicine 
department for investigation. Immunological parameters (antinuclear antibody, rheumatoid factor, ACPA, ANCA, Coombs) and kidney 
investigations were negative. A lymph node biopsy showed the presence of non-necrotizing granuloma (Fig. 2). New ocular symptoms were 
diagnosed as granulomatous uveitis. 
There was a strong suspicion of sarcoidosis because of the pulmonary involvement, the ocular and joint manifestations, the presence of 
granulomatous disease in the biopsy and the non-response to anti-TB drugs. The work-up showed normal angiotensin converting enzyme 
and calcium and phosphorus levels. Lymphoma was also a possible diagnosis but an immunohistochemistry study performed on the lymph 
node biopsy was negative as was a bone marrow biopsy. Protein electrophoresis showed hypogammaglobulinaemia (Fig. 3).
Further investigations revealed decreased serum immunoglobulin levels: IgG 1.1, IgA 0.3 and IgM 0.4. A flow cytometric study of lymphocyte 
subpopulations showed a low CD19 count (2%) with a normal range of T lymphocytes. These findings suggested a primary immunodeficiency, 
in particular CVID.
Figure 1. Chest radiograph showing micronodular and interstitial infiltrates in 
both lungs
Figure 2. Node biopsy showing non-necrotizing granuloma
Figure 3. Protein electrophoresis showing hypogammaglobulinaemia
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In light of these results, a CVID with granulomatous manifestations was diagnosed based on European Society for Immunodeficiencies 
(ESID) criteria (Table 1). Our patient was treated with immunoglobulin perfusions, oral corticosteroids (especially for the ocular involvement), 
respiratory physiotherapy and azithromycin for bronchiectasis. Evolution was good: the fever resolved, respiratory symptoms have 
improved, and our patient has gained weight and recovered her vision.
 At least one of the following:
• Increased susceptibility to infection
• Autoimmune manifestations
• Granulomatous disease
• Unexplained polyclonal lymphoproliferation
• Affected family member with antibody deficiency
AND
• A marked decrease in IgG and marked decrease in IgA with or without low IgM levels (measured at least twice; 
<2 SD of the normal levels for the patient’s age)
AND
Either:
•  Poor antibody response to vaccines (and/or absent isohaemagglutinins)
Or:
• Low switched memory B cells (<70% of age-related normal value)
AND
• Age ≥4 years
AND
No evidence of T cell deficiency defined as two of the following:
•  CD4 count (cells/µl): 2–6 years <00, 6–12 years <250, >12 years <200
• % Naive CD4: 2–6 years <25%, 6–16 years <20%, >16 years <10%
• T cell proliferation absent
Table 1. European Society for Immunodeficiencies (ESID) 2014 criteria for common variable immunodeficiency (CVID)[3]
DISCUSSION
Few cases of primary immunodeficiency are reported in patients over 40 years of age[1]. Practitioners rarely consider primary 
immunodeficiency, especially in older patients or in the absence of recurrent infections, as in our case, which can cause diagnostic delay 
resulting in complications such as bronchiectasis and excess mortality. 
Granulomatous manifestations are seen in 8–22% of CVID patients[2], which should encourage practitioners to consider it. These patients 
present with a clinical picture that mimics sarcoidosis, hence the description ‘sarcoidosis-like’ with unusual hypogammaglobulinaemia[2]. 
Several signs mentioned in this case report can also be seen in sarcoidosis, granulomatous uveitis, lymphadenopathy and disease with 
respiratory involvement and histological evidence of granuloma. Before retaining CVID as a diagnosis, practitioners should first exclude 
common causes of hypogammaglobulinaemia such as nephrotic syndrome, protein loss enteropathy, lymphoma and drugs (chemotherapy, 
corticosteroids, etc.).
We did not explore this primary immunodeficiency further because of financial constraints. However, CVID can be characterized with B cell 
immunophenotyping, where the granulomatous profile shows a severe reduction in switched memory B cells and a high level of CD21low 
B cells[2, 3].
We did not perform genetic analysis in our patient either because of technical problems. The genetic origin of CVID is still obscure, but 
it has been well established that CVID is a highly heterogeneous and polygenic disease; several studies have described inducible T cell 
costimulator (ICOS), tumour necrosis factor receptor superfamily member 13B (TNFRSF13B, also known as TACI), tumour necrosis factor 
receptor superfamily member 13C (TNFRSF13C, also known as BAFFR) and D19 genetic polymorphisms[3].
Our patient was successfully treated with monthly immunoglobulin perfusions. Immunoglobulin perfusions have shown efficacy in decreasing 
infectious events and in exerting anti-inflammatory effects[3, 4]. The presence of granulomatous manifestations requires specific treatment 
because they evolve independently and do not respond to immunoglobulin replacement alone[3]. Corticosteroids remain the cornerstone 
of treatment for granulomatous manifestations but sometimes are insufficient to obtain remission. However, other immunosuppressive 
therapies can be used such as rituximab or azathioprine, but do present an increased risk of infectious complications[2]. Bronchiectasis was 
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the second main problem in our patient and is generally managed with respiratory physiotherapy. Bronchiectasis is correlated with a poor 
prognosis and has an independent clinical course which responds poorly to immunoglobulin perfusions[3]. The use of azithromycin for its 
anti-inflammatory effect has improved the quality of life in such patients[5].
A clinical picture of sarcoidosis associated with hypogammaglobulinaemia should suggest a diagnosis of CVID at any age, even in the absence 
of a typical history of recurrent infections. However, one should be very careful to exclude common causes of immunoglobulin loss before 
considering CVID.
